LYKA LABS
|
The Current P/S Ratio of LYKA LABS is 1.57.
| Share Price | ₹59.0 | Apr 07,2026 |
| Market Cap | ₹210.6 Cr | |
| Sales-TTM | ₹133.8 Cr | TTM-Consolidated Results |
| Price/Sales | 1.57x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of LYKA LABS
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹210.6 Cr] as on Apr 07,2026
(/) Sales [ ₹133.8 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 1.57x ]
Thus, for LYKA LABS , the investors are currently willing to pay '1.57 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of LYKA LABS !
The chart below summarizes the trend in P/S Ratio of LYKA LABS over the last five years.
Historical PS (Price/Sales) ratio chart of LYKA LABS
PS Ratio Performance Analysis for LYKA LABS
- LYKA LABS 's p/e ratio for fiscal years ending Mar2025 to Mar2021 averaged 2.41x.
- LYKA LABS 's operated at median p/e ratio of 2.6x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, LYKA LABS 's p/e ratio peaked in Mar2023 at 3.45x.
- LYKA LABS 's p/e ratio hit its five-year low in Mar2021 of 0.86x.
How does LYKA LABS 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| LYKA LABS | 133.8 | 1.57 | 210.6 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.26 | 412,326.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 15.06 | 155,282.0 |
| CIPLA LTD | 28,351.1 | 3.43 | 97,115.7 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 10.76 | 137,043.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 2.88 | 99,854.2 |
| MANKIND PHARMA LTD | 13,914.1 | 6.05 | 84,231.4 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.37 | 87,909.6 |
| LUPIN LTD | 26,150.5 | 4.02 | 104,996.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.33 | 77,223.4 |
| ABBOTT INDIA LTD | 6,824.1 | 7.99 | 54,530.0 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs LYKA LABS 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 1.57x |
| Max industry PS | 15.06x |
| Median industry PS | 4.02x |
| Average industry PS | 5.88x |
You may also like the below Video Courses